Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Applied BioMath, LLC Announces Collaboration with Asher Biotherapeutics for Systems Pharmacology Modeling in Oncology
Wednesday, March 31, 2021Applied BioMath wwwappliedbiomathcom the industryleader in applying systems pharmacology and mechanistic modeling simulation and analysis to derisk drug research and development announced a collaboration with Asher Biotherapeutics for systems pharmac...
Tarsus Pharmaceuticals and LianBio Announce Strategic Partnership to Develop and Commercialize TP-03 in Greater China
Tuesday, March 30, 2021Tarsus Pharmaceuticals Inc a late clinicalstage biopharmaceutical company and LianBio a biotechnology company dedicated to bringing paradigmshifting medicines to patients in China and major Asian markets announced a strategic partnership to develop a...
Hansa Biopharma enters preclinical research collaboration with argenx
Tuesday, March 30, 2021Hansa Biopharma AB Hansa a pioneer in enzyme technology for rare immunological conditions announced that they have entered into a preclinical research collaboration agreement with argenx BV to evaluate the therapeutic potential of combining the two c...
Astellas Receives Positive CHMP Opinion for XTANDITM (enzalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer
Monday, March 29, 2021Astellas Pharma Incannounced the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has adopted a positive opinion recommending an additional indication for the oral oncedaily therapy XTANDITM enzalutamide for ad...
Twist Bioscience and Kyowa Kirin Partner for GPCR Antibody Discovery
Friday, March 26, 2021Twist Bioscience Corporation a company enabling customers to succeed through its offering of highquality synthetic DNA using its silicon platform today announced that it signed a partnership agreement with Kyowa Kirin Pharmaceutical Research Inc a su...
Bright Peak Therapeutics Inc. and Ajinomoto Co., Inc. Enter into a Research Collaboration and License Agreement to Create Novel Immunocytokines
Friday, March 26, 2021Bright Peak Therapeutics Inc a biotechnology company developing next generation immunotherapies for cancer and autoimmune disease and Ajinomoto Co Inc Ajinomoto Co a leading technology provider for biopharmaceuticals and the owner of Ajinomoto BioPha...
Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies
Thursday, March 25, 2021A broad coalition of biopharmaceutical and technology leaders announced a new strategic collaboration to promote new and updated standards for advanced therapies The new collaboration which will work across the biopharmaceutical and technology sector...
Exacis Biotherapeutics Develops mRNA-Engineered iPSC-Derived NK Cells For Difficult-To-Treat Tumors
Thursday, March 25, 2021Exacis Biotherapeutics Inc a developmentstage immunooncology company working to democratize access to the most advanced and effective cancer treatments announced several important steps in the preclinical development of its ExaNK engineered NK cellth...
Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats
Wednesday, March 24, 2021Cipla Therapeutics a division of Cipla USA Inc an affiliate of Cipla Limitedand SIGA Technologies Inc a commercialstage pharmaceutical company focused on the health security market announced entering into a strategic partnership to deliver sustained...
Dunad Therapeutics Emerges To Develop Next-generation Small Molecule Therapeutics Based On First Tuneable Targeted Protein Degradation Technology
Wednesday, March 24, 2021Dunad Therapeutics Dunad emerges to develop nextgeneration small molecule therapeutics based on its highly differentiated tuneable and targeted protein degradation technology Dunad secured initial financing from Epidarex Capital
